China Asthma Management White Paper Officially Released on World Asthma Day

Asthma has become one of the most prevalent diseases worldwide, particularly among children, where its spread is even more widespread. According to estimates by the Global Initiative for Asthma (GINA), approximately 300 million people globally are affected by asthma; the World Health Organization (WHO) predicts that the number of asthma patients will rise to 400 million by 2025. In China, the number of asthma patients has increased from less than 20 million a decade ago to 30 million, and the patient population continues to grow steadily.

The first Tuesday of May each year, which is today, is designated as World Asthma Day. This commemorative initiative, launched by the World Health Organization, aims to enhance public awareness of the current status of asthma and strengthen prevention and control efforts among patients and the general population. On this day, Asthma Manager, in collaboration with VCBeat, officially released the White Paper on the Current Status of Asthma Management in China. The report is based on data from 278,306 asthma patients, collected through tens of thousands of intelligent medication monitoring devices and smart respiratory warning instruments.

Curious about the real landscape of asthma treatment in China? Which cities demonstrate better asthma control? What are the most popular medications among asthma patients online? What are the common misconceptions in asthma treatment? How can you achieve better asthma control using the most advanced management methods? Join us as we explore these questions in this white paper.